NOTE 11 - SHAREHOLDERS EQUITY |
3 Months Ended |
|---|---|
Jan. 31, 2025 | |
| Equity [Abstract] | |
| NOTE 11 - SHAREHOLDERS EQUITY | NOTE 11 - SHAREHOLDERS EQUITY
Preferred Stock
The authorized preferred stock of the Company consists of 200,000,000 shares with a par value of $0.0001. The authorized Series A Preferred Stock of the Company consists of 100,000,000. There were 10,000,000 shares of Series A Preferred Stock issued and outstanding as of January 31, 2025 and October 31, 2024.
The rights, preferences, privileges, restrictions and other matters relating to the Series A Preferred Stock are as follows:
(a) Each share of Series A Preferred Stock shall have no voting rights; (b) Each shareholder of Series A Preferred Stock may convert their shares at the option of the holder thereof into an equal amount of shares of any other class or series of the Company’s stock on a one-to-one basis.
Common Stock
The authorized common stock of the Company consists of 200,000,000 shares with a par value of $0.0001. There were 11,997,350 and 11,560,350 shares of common stock issued and outstanding as of January 31, 2025 and October 31, 2024, respectively.
During the period ended January 31, 2025, 437,000 shares of common stock were issued to 31 shareholders for proceeds totaling $5,244,000 by an S-1 offering deemed effective on August 23, 2023 and extended to November 2024.
During the year ended October 31, 2024, 743,000 shares of common stock were issued to 43 shareholders for proceeds totaling $8,565,948 by an S-1 offering deemed effective on August 23, 2023 and extended to November 2024.
|